Matteo Rosellini
9PUBLICATIONS
44CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Oct 29, 2025
Sarcomatoid Differentiation in Renal Cell Carcinoma: Clinical and Pathologic Heterogeneity and Outcomes With Immune Checkpoint Inhibitors-Data From the ARON-1 Study.Francesco Massari, Matteo Rosellini, Bohuslav Melichar
|Oct 16, 2024
Novel Immune Checkpoint Inhibitor Targets in Advanced or Metastatic Renal Cell Carcinoma: State of the Art and Future Perspectives.Samuele Compagno, Chiara Casadio, Linda Galvani
|May 17, 2024
Overall survival with adjuvant pembrolizumab in renal cell carcinoma - the shock of the lightning.Francesco Massari, Matteo Rosellini, Veronica Mollica
|Nov 16, 2022
Immune checkpoint inhibitors in lung tumors with rare histologies and other thoracic malignancies.Elisa Andrini, Alessandro Di Federico, Monia Sisi
|Sep 09, 2022
Adjuvant PD-1 and PD-L1 Inhibitors and Relapse-Free Survival in Cancer Patients: The MOUSEION-04 Study.Alessandro Rizzo, Veronica Mollica, Andrea Marchetti
|Aug 25, 2022
Prognostic Factors of Survival for High-Grade Neuroendocrine Neoplasia of the Bladder: A SEER Database Analysis.Veronica Mollica, Francesco Massari, Elisa Andrini
Pageof 2
Frequent Collaborators
7 joint publications
Francesco Massari
5 joint publications
Andrea Marchetti
3 joint publications
Alessandro Rizzo
2 joint publications
Alessia Cimadamore
2 joint publications
Giacomo Nuvola
2 joint publications
Rodolfo Montironi
2 joint publications
Enrique Grande
2 joint publications
Fernando Sabino Marques Monteiro
2 joint publications
Javier Molina-Cerrillo
1 joint publications
Yüksel Ürün
